ROBERT VICE: Open Payments
NPI 1750087318 · TUSCALOOSA, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 8 payments from 6 companies in 2025. Trend: 2023 $211 · 2024 $473 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 2 | $236 |
| Novo Nordisk Inc | 2 | $212 |
| Otsuka America Pharmaceutical, Inc. | 1 | $125 |
| Amgen Inc. | 1 | $122 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $104 |
| Corcept Therapeutics | 1 | $17 |
Products named: Auvelity, Wegovy, REXULTI, JARDIANCE, Korlym.
Industry payments across AL — which companies pay providers there.
